Finnish high-tech company FocalSpec, specialized in devices for fast surface measurement and on-line testing of challenging materials and shapes, and Digital Surf, global provider of Mountains® surface analysis software solutions, have teamed up to release FocalSpec Map, a cutting-edge software package bringing a whole new set of tools to users of the Finnish company’s innovative Line Confocal Imaging (LCI) technology....

Optical Surfaces Ltd. has received an order from Strathclyde Intense Laser Interaction Studies (SILIS) Group, from University of Strathclyde (UK) for three ultra-high performance off-axis parabolic mirrors in special custom vacuum motorised mounts. The mounted mirrors to be developed by Optical Surfaces Ltd. will be used on several beamlines of the facilities 350TW laser which is designed to support an extensive research portfolio in laser-plasma physics and multidisciplinary applications....

Forensics Europe Expo | 6-7 March 2018 | Olympia, London

With an incredible speaker line up, dozens of free seminars, tonnes of innovation and an exhibition of the latest technology, Forensics Europe Expo is gearing up to be the must-attend event for today’s modern forensic professional.

Metrohm is pleased to announce the acquisition of Innovative Photonic Solutions (IPS). With this important acquisition, Metrohm continues to invest in strategic growth and enhances the company’s capabilities to further develop a portfolio of industry-leading Raman solutions.IPS is the largest producer of Raman spectroscopy diode-based light components in the world. Founded in 2003, the company’s products range from simple components such as packaged diodes and OEM modules that include....

Ingenza has joined forces with leading universities and industrial partners to participate in the ConBioChem collaboration, a translational project focused on the development of novel platform technologies for the continuous bio-production of commodity chemicals. The consortium, led by Professor Gill Stephens of the University of Nottingham, recently achieved success in the Industrial Biotechnology Catalyst – a multi-million pound competition funded by Innovate UK, BBSRC and EPSRC – resulting in the award of £3.46 million over a five-year period....

Karl Landsteiner University of Health Sciences, Technische Universität Wien and the Medical University of Vienna present the findings of the largest water hygiene study of its kind. Despite wastewater management and treatment plants, human waste remains the main source of microbial faecal pollution in the river Danube. This is the most notable finding of a comprehensive analysis of faecal pollution in the Danube. The study used a new molecular genetics method that enables the clear differentiation of human microbial....

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The new Gyrolab^® Generic TK Kit adds to a growing menu of ready-to-use kits, and allows researchers to more efficiently quantify human therapeutic antibodies (IgG) in automated, nanoliter-scale Gyrolab xP and Gyrolab xPlore™ systems....

When working in laboratories and hospitals, it’s crucial that any contaminants found in water are removed immediately, before they cause any damage. Each impurity carries its own risks to chemical and biological research, not to mention the detrimental effect they cause to the quality of pure water. Here, Triple Red discuss the 8 main types of water contaminants, and how they can be prevented....

JPK Instruments reports on the ground-breaking research into the understanding of the reproduction of retroviruses such as HIV at Ben-Gurion University in Beer-Sheba, Israel. Professor Itay Rousso leads a research group in the Department of Physiology and Cell Biology at Ben-Gurion University in Beer Sheba. Their focus is to uncover the physical mechanism underlying the replication machinery of enveloped retroviruses (primarily HIV)....

BioNTech Diagnostics GmbH is announcing new results from two studies on the MammaTyper® test which were presented at the Breast Cancer Symposium in San Antonio in December.The results of these studies again demonstrate the benefits of breast cancer subtyping using MammaTyper® to predict the course of the disease and to aid in the selection of effective, tailored therapy. MammaTyper® allows precise, quantitative measurement of the mRNA expression of the ERBB2 (HER2), ESR1 (ER), PGR (PR) and  MKI67 (proliferation marker Ki-67) biomarkers, which in turn facilitates molecular subtyping of tumor tissue according to...

Linkam Scientific Instruments, report on the work of Dr Henning Gieseler from the Friedrich-Alexander University (FAU) Erlangen-Nuremberg on his research and development activities in the field of freeze drying for the pharmaceutical industry. Dr Henning Gieseler leads the Freeze Drying Focus Group (FDFG) in the Division of Pharmaceutics at the Friedrich-Alexander University (FAU) Erlangen-Nuremberg. He started his research in this area in 2006 after first coming across freeze drying microscopy....

Powder characterisation specialists, Freeman Technology, will be exhibiting at Analytica for the first time in Hall A2 Stand 423 (10 – 13 April 2018, Muenchen, Germany). With a direct operation now established in Germany, the company will be showcasing their material characterisation solutions designed to optimise process performance, increase productivity and improve quality in a diverse range of sectors....

It may seem like a convoluted analogy but actually the comparison is profoundly linked to how diagnostic medicine is changing thanks to technology.

Wind back 15 years and the real power of getting a solution, i.e. assembling a team, was with the sports scouts, by feel, using their experience to spot opportunities and create balanced teams based on small budgets. The back-room boys, modelling of pre-existing data-sets to extrapolate patterns, able to influence broad strategies but little in the way of hands-on selection of who plays in which game...

SYGNIS AG has announced it has extended the manufacturing capability for its Lightning-Link^® technology, currently marketed under the Innova Biosciences brand, to support scalability and bulk production of antibodies.

Lightning-Link is an innovative technology that enables direct labeling of antibodies or proteins in as little as 20 minutes, for use in R&D applications, drug discovery and the development of diagnostic kits. Lightning-Link kits are the world’s fastest, easiest to use and most efficient method of labeling antibodies....

Tumors often comprise groups of cancer cells that show differential drug sensitivities.

This is one of the reasons that initially effective treatments usually do not lead to long-term benefit in patients. Researchers from the Netherlands Cancer Institute in Amsterdam, in collaboration with the international biotechnology company Genmab A/S, have now developed a new strategy to tackle this problem....

Whether for use in research or general laboratory applications, the performance and build quality of the Priorclave QCS range of front loading autoclaves has made it a global success. 

Due to its popularity the company will be highlighting its smallest steam steriliser from the range at next month’s Medlab exhibition in Dubai – 5^th to 8^th February 2018. Visitors to stand Z1 - C58 will have the opportunity examine first-hand the superior build quality of the Priorclave QCS EH100, a 100 litre laboratory autoclaves.

TIDE detects genome editing-mediated indels and calculates the efficiency of CRISPR using Sanger DNA sequencing data

Desktop Genetics Ltd (DTG), a biotech company globally recognised for its leadership in gene-editing bioinformatics, acquired exclusive worldwide licensing rights for TIDE (Tracking of Indels by DEcomposition), from the Netherlands Cancer Institute (NKI)....

Avacta Group plc is pleased to announce that its initial study with Glythera Limited, the developer of next generation antibody drug conjugates, has concluded successfully. 

Following this study the two companies have agreed the terms of a licensing deal which will allow them to develop drug conjugates using the combined technologies.  The detailed terms of the license have not been disclosed but Avacta would receive development milestone payments and royalties

Global chromatography syringes market is expected to reach USD 178.1 million by 2022, at a CAGR of 5.7% during the forecast period of 2017 to 2022.

The growth of this market is mainly attributed by the increasing investment and funding for life sciences research, growing use of chromatography techniques in drug approval, increased funding for chromatography technologies by regional governments, various technological advancements, and increasing investments by the major players in emerging markets....

This year, BMG LABTECH’s Australian office celebrates 20 years of innovation and steady growth.

The office was established in January 1998 to support Australia and the APAC region, offering excellent sales and customer service for BMG LABTECH’s wide range of dedicated and multi-mode microplate readers. “Since its incorporation there have been many changes at BMG LABTECH....

Save more money with Pop-Bio Pop-Bio, the fast-growing Cambridge based company, offer a number of its family of brands to the life science market. Launched at the end of 2016, Pop-Bio has established itself as central point for its sister company brands of Vivantis, Hercuvan and Stemmera. Additionally, from April 2018, Pop-Bio will also be launching a brand new product for gel and blot imaging using its latest patented technologies.....

Imcyse SA announces that it has entered into a research collaboration with Pfizer Inc. for development of an Imotope™, a specific modified peptide, targeting rheumatoid arthritis (RA).

Under the terms of the agreement, Pfizer will provide an undisclosed amount to fund the research activities, and Pfizer has an exclusive option to negotiate a license agreement for a limited period following the research activities....